Share story
Capital AI

Project Ventures launches €5.8 million fund for Imperial-linked deep-tech startups

Project Ventures launches €5.8 million fund for Imperial-linked deep-tech startups Image: Primary
Project Ventures launched a €5.8 million (£5 million) fund to back pre-seed and seed companies connected to Imperial College London and working across deep technology and AI. The firm plans investments of €116k (£100k) to €349k (£300k) and has already backed Tewke, NexusAM and Neubond. More than 80% of the fund's limited partners are Imperial alumni. Its stated focus includes energy, advanced manufacturing, robotics and healthcare, and it aims to close the fund by summer 2027. The vehicle is therefore launched but has not yet reached its planned final close.
Sources
EU-Startups
Published by Tech & Business, a media brand covering technology and business. This story was sourced from EU-Startups and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Onlinekhabar English
Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

Infosecurity Magazine
AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Techmeme
Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...

EU-Startups